Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti-Cancer Agents

Volume 9

eBook: US $59 Special Offer (PDF + Printed Copy): US $95
Printed Copy: US $65
Library License: US $236
ISSN: 2451-8905 (Print)
ISSN: 2215-0803 (Online)
ISBN: 978-981-5223-92-7 (Print)
ISBN: 978-981-5223-91-0 (Online)
Year of Publication: 2024
DOI: 10.2174/97898152239101240901

Introduction

Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. Volume 9 features reviews on these topics:

  • - Dietary Strategy for Cancer Therapy - Amino Acid Restrictions and Beyond
  • - The Revolutionary Potential of Noble Metal Nanoparticles as Anti-Cancer Agents: State-of-the-Art Applications and Future Perspectives
  • - Algal Polysaccharides as Promising Anticancer Agents
  • - Cardiotoxicity Caused by Doxorubicin and Trastuzumab: Current Understanding for Future Preventive Strategies
  • - Emodin: Anticancer Agent

Contributors

Editor(s):
Atta-ur-Rahman FRS
Kings College, University of Cambridge
Honorary Life Fellow
Cambridge
UK




Contributor(s):
Anamika Sharma
Pharmacology and Toxicology Lab
Dietetics and Nutrition Technology Division, CSIR-Institute of Himalayan Bioresource Technology
Palampur, H.P.
India


Christian Pasquali
Department of Scientific Affairs
OM Pharma
Meyrin
Switzerland


Daniel Zingg
Department of Scientific Affairs
OM Pharma
Meyrin
Switzerland


Giovanni A. Rossi
Pediatric Pulmonology and Allergy Unit
Istituto Giannina Gaslini
Genoa
Italy


Ghoson M. Daba
Chemistry of Natural and Microbial Products Department
Pharmaceutical Industries Researches Institute, National Research Centre, El Buhouth St.
Dokki, 12311, Giza
Egypt


Hermann Haller
Department of Nephrology and Hypertension
Hannover Medical School
Hannover
Germany


Marwa O. Elnahas
Chemistry of Natural and Microbial Products Department
Pharmaceutical Industries Researches Institute, National Research Centre, El Buhouth St.
Dokki, 12311, Giza
Egypt


Mayukh Hore
Immunopharmacology and Molecular Cell Biology Laboratory
Department of Zoology, University of Gour Banga
Malda – 732103, West Bengal
India


Patil Shivprasad Suresh
Chemical Technology Division
CSIR-Institute of Himalayan Bioresource Technology
Palampur, H.P.
India


Stefania Ballarini
Department of Scientific Affairs
OM Pharma
Meyrin
Switzerland


Sayan Bhattacharyya
All India Institute of Hygiene & Public Health
Kolkata
India


Subhrajyoti Roy
Immunopharmacology and Molecular Cell Biology Laboratory
Department of Zoology, University of Gour Banga
Malda – 732103, West Bengal
India


Shubham Bhattacharyya
Immunopharmacology and Molecular Cell Biology Laboratory
Department of Zoology, University of Gour Banga
Malda – 732103, West Bengal
India


Waill A. Elkhateeb
Chemistry of Natural and Microbial Products Department
Pharmaceutical Industries Researches Institute, National Research Centre, El Buhouth St.
Dokki, 12311, Giza
Egypt


Yogendra Padwad
Pharmacology and Toxicology Lab
Dietetics and Nutrition Technology Division, CSIR-Institute of Himalayan Bioresource Technology
Palampur, H.P.
India